Novel therapeutics, enhancements to existing treatments, and new uses for existing compounds are all of interest to LSGPA. In particular, we seek potential investments in translational stage therapeutics (late preclinical to early clinical) from academic labs and young discovery companies. Innovative CROs and novel approaches to clinical trials management will also be considered.
Azevan Pharmaceuticals, Inc., is a clinical stage, small molecule drug development company developing...Read MoreImmunomic Therapeutics, Inc.Lancaster, PA
Immunomic Therapeutics, Inc., (ITI) is a clinical stage biotechnology company with a novel...Read MoreIndigo Biosciences, Inc.State College, PA
Indigo Biosciences offers to academic labs, contract research organizations, and pharmaceutical and biotechnology...Read More